ストックスクリーナーアプリを入手
14.67
0.07%
0.010
アフターアワーズ：
14.67
前日終値:
$14.68
開ける：
$14.68
24時間の取引高:
381.28K
Relative Volume:
0.54
時価総額：
$650.16M
収益：
$200.93M
当期純損益:
$-18.91M
株価収益率:
-33.20
EPS:
-0.4419
ネットキャッシュフロー:
$-9.09M
1週間 パフォーマンス:
-1.01%
1か月 パフォーマンス:
+8.65%
6か月 パフォーマンス:
-24.59%
1年 パフォーマンス:
-20.08%
1日の値動き範囲:
$14.43
$14.77
1週間の範囲:
$14.31
$15.10
52週間の値動き範囲:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
名前
Si Bone Inc
セクター
電話
(408) 207-0700
住所
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.66 | 651.05M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-27 | 開始されました | TD Cowen | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-03-28 | 開始されました | Piper Sandler | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-04-07 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 開始されました | Citigroup | Buy |
| 2021-03-09 | 繰り返されました | Needham | Buy |
| 2020-12-16 | 繰り返されました | Needham | Buy |
| 2020-08-04 | 繰り返されました | Needham | Buy |
| 2020-06-16 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 繰り返されました | Needham | Buy |
| 2020-02-19 | 開始されました | Needham | Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 開始されました | BofA/Merrill | Buy |
| 2018-11-12 | 開始されました | Canaccord Genuity | Buy |
| 2018-11-12 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-11-12 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Si Bone Inc (SIBN) 最新ニュース
SI-BONE's strong revenue growth hasn't boosted its share price, raising questions about market sentiment or underlying issues. Caution is advised for investors, with analysts taking a neutral to slightly bearish stance until profitability or improvement is shown. - Moomoo
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares - Investing.com India
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares By Investing.com - Investing.com Nigeria
Si-Bone CEO Laura Francis sells $220,000 in company stock - Investing.com
Si-Bone CEO Laura Francis sells $220,000 in company stock By Investing.com - Investing.com Australia
SI-BONE (SIBN) CEO Laura Francis sells 14,957 shares to cover RSU tax bill - Stock Titan
SI-BONE (SIBN) legal chief sells 3,726 shares in tax sell-to-cover - Stock Titan
Tax-related SI-BONE (SIBN) CFO sale of 4,666 shares disclosed - Stock Titan
How much upside is left in Si-Bone (SIBN)? Wall Street analysts think 65.27% - MSN
Earnings call transcript: Si-Bone Q1 2026 beats EPS forecast, stock rises - Investing.com Nigeria
(SIBN) Volatility Zones as Tactical Triggers - Stock Traders Daily
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27% - Yahoo Finance
SI-BONE stock (US8255921098): Q1 beat and raised FY26 guidance drive gains - AD HOC NEWS
Analysts Have Been Trimming Their SI-BONE, Inc. (NASDAQ:SIBN) Price Target After Its Latest Report - simplywall.st
SiBone $SIBN Shares Bought by HighMark Wealth Management LLC - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX) - The Globe and Mail
SI-BONE (SIBN) Reports Strong Q1 Earnings and Raises Full-Year G - GuruFocus
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
SI-BONE 1Q Loss/Shr 10c >SIBN - Moomoo
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18 - Moomoo
SIBN Maintained by TD Cowen -- Price Target Lowered to $18 - GuruFocus
SIBN Reiterated by Truist Securities -- Price Target Lowered to $18.00 - GuruFocus
Truist cuts SI-BONE stock price target on conservative guidance By Investing.com - Investing.com Australia
Truist cuts SI-BONE stock price target on conservative guidance - Investing.com UK
SI-BONE targets $230M-$233M 2026 revenue while CMS proposes new DRGs that could add up to $50,000 per Granite procedure - MSN
SI-BONE, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SIBN) 2026-05-12 - Seeking Alpha
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2026 Earnings Call Transcript - Insider Monkey
SI-BONE net loss hits USD 4.3M in Q1 2026 - Medical Buyer
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Truist Lowers Price Target on SI-BONE to $18 From $20, Keeps Buy Rating Rating - Moomoo
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Reve - GuruFocus
SI-BONE Surges on Strong Q1, Raises Guidance Amid Innovation Push - BriefGlance
SI-BONE Q1 2026 slides: profitability surges, physician base expands By Investing.com - Investing.com Australia
SiBone Q1 Earnings Call Highlights - inkl
Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $18 - Moomoo
SiBone Q1 2026 Earnings Call Transcript - MarketBeat
Is SI-BONE (SIBN) Still 45.2% Undervalued After Q1 2026 Beat? EP - GuruFocus
SIBN Reports Positive Outlook with Strong Gross Margin - GuruFocus
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
SIBN Reports Strong Q1 Performance with Revenue Growth - GuruFocus
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SI-Bone (SIBN) Q1 2026 Earnings Transcript - The Globe and Mail
Si Bone Inc (SIBN) 財務データ
収益
当期純利益
現金流量
EPS
Si Bone Inc (SIBN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
May 18 '26 |
Sale |
14.63 |
3,726 |
54,527 |
280,509 |
| Maheshwari Anshul | Chief Financial Officer |
May 18 '26 |
Sale |
14.69 |
4,666 |
68,523 |
259,877 |
| DUNN JEFFREY W | Director |
May 04 '26 |
Sale |
13.15 |
337 |
4,432 |
9,157 |
| Hinckley Greg K | Director |
Apr 07 '26 |
Option Exercise |
5.94 |
3,085 |
18,325 |
105,135 |
| Maheshwari Anshul | Chief Financial Officer |
Apr 02 '26 |
Sale |
12.87 |
3,318 |
42,708 |
263,148 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Apr 01 '26 |
Sale |
12.95 |
1,799 |
23,302 |
284,175 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Apr 02 '26 |
Sale |
12.86 |
1,335 |
17,164 |
282,840 |
| Nishimura Mika | Director |
Mar 12 '26 |
Sale |
13.83 |
4,100 |
56,700 |
32,716 |
1.35%
2.06%
大文字化:
|
ボリューム (24 時間):